Categories
BLOG

medical cannabis research act

H.R.601 – Medical Cannabis Research Act of 2019 116th Congress (2019-2020) |

Sponsor: Rep. Gaetz, Matt [R-FL-1] (Introduced 01/16/2019)
Committees: House – Energy and Commerce; Judiciary; Veterans’ Affairs
Latest Action: House – 03/04/2019 Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. (All Actions)

Tracker:

This bill has the status Introduced

Here are the steps for Status of Legislation:

More on This Bill

  • Constitutional Authority Statement
  • CBO Cost Estimates [0]

Subject — Policy Area:

  • Health
  • View subjects

Summary: H.R.601 — 116th Congress (2019-2020) All Information (Except Text)

There is one summary for H.R.601. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (01/16/2019)

Medical Cannabis Research Act of 2019

This bill establishes a new, separate registration process for manufacturers of cannabis for research.

As a part of this process, the Drug Enforcement Administration must annually assess whether there is an adequate and uninterrupted supply of research cannabis and register additional manufacturers.

The bill also authorizes health care providers of the Department of Veterans Affairs to provide information to veterans regarding participation in federally approved cannabis clinical trials.

Summary of H.R.601 – 116th Congress (2019-2020): Medical Cannabis Research Act of 2019 ]]>